— Know what they know.
Not Investment Advice
Also trades as: HEXO.TO (TSX) · $vol 0M

HEXO NASDAQ

HEXO Corp.
1W: -7.9% 1M: -50.4% 3M: -42.7% 1Y: -75.6% 3Y: -98.3% 5Y: -99.7%
$0.71
Last traded 2023-06-22 — delisted
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · $31.2M mcap · 38M float · 0.934% daily turnover

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$191M +54.4% ▲
5Y CAGR: +115.7%
Gross Profit
-$76M -255.1% ▼
Operating Income
-$1.1B -2357.4% ▼
Net Income
-$1.1B -835.5% ▼
EPS (Diluted)
$-38.68 -206.5% ▼
EBITDA
-$258M -619.9% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2018FY2019FY2020FY2021FY2022
Revenue$5M$48M$81M$124M$191M
YoY Growth+20.4%+863.5%+69.9%+53.2%+54.4%
Cost of Revenue-$1M$21M$139M$75M$267M
Gross Profit$6M$27M-$58M$49M-$76M
Gross Margin129.7%56.6%-71.8%39.4%-39.6%
R&D Expenses$0$3M$5M$4M$3M
SG&A Expenses$23M$105M$91M$80M$122M
Operating Expenses$24M$111M$419M$92M$154M
Operating Income-$18M-$85M-$477M-$43M-$1.1B
Operating Margin-364.1%-177.9%-589.9%-35.1%-558.7%
Interest Expense$2M$469K$10M$32M$20M
Income Before Tax-$23M-$85M-$553M-$115M-$1.1B
Tax Expense$0-$4M-$6M-$397K-$39M
Net Income-$23M-$82M-$546M-$115M-$1.1B
Net Margin-473.2%-171.6%-676.5%-92.7%-561.8%
EPS (Diluted)$-9.75$-21.47$-63.43$-12.62$-38.68
EBITDA-$14M-$79M-$477M-$36M-$258M
Shares Outstanding2M4M9M9M28M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms